Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code
Uveitis (2122)
Date of Event
11/27/2024
Type of Reportable Event
Serious Injury
Event or Problem Description
A site reported to rxsight that on (b)(6) 2024, 1 week following the lock-in light treatment, the patient was prescribed antiviral medication to treat herpes zoster ophthalmicus (hzo).Topical steroid was subsequently added to treat an associated uveitis.Symptoms were resolved on (b)(6) 2025, and the patient proceeded to complete the final lock-in light treatment.
Additional Manufacturer Narrative
The device history record was reviewed and there were no discrepancies or unusual findings.The manufacturer's reference #: (b)(4).